This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
3 HMO Stocks to Consider as Aetna (AET) Falls Out of Favor
by Zacks Equity Research
Aetna Inc. (AET) has been grappling with a number of issues of late, which are clearly reflected in its share price underperformance relative to the sector.
Aetna Continues to Grow Business, Merger Remains Uncertain
by Zacks Equity Research
On Dec 27, we issued an updated research report on Aetna Inc. (AET).
Why UnitedHealth (UNH) Stands Tall Amid All the Noise
by Zacks Equity Research
UnitedHealth (UNH) has been able to beat all kinds of industry odds to emerge as a winner.
Will You Hold Humana (HUM) Amid Aetna Merger Uncertainty?
by Zacks Equity Research
On Dec 19, 2016, Zacks Investment Research downgraded Humana Inc. (HUM) to a Zacks Rank #3 (Hold).
Zacks.com featured highlights: Nxstage Medical, Humana, Motorola Solutions, Evercore Partners and NTN Buzztime
by Zacks Equity Research
Zacks.com featured highlights: Nxstage Medical, Humana, Motorola Solutions, Evercore Partners and NTN Buzztime
UnitedHealth's Upcoming Note Issuance Rated by A.M Best
by Zacks Equity Research
UnitedHealth Group's (UNH) upcoming senior unsecured notes of $1.5 billion recently received rating action from A.M. Best. The rating giant has assigned a Long-Term Issue Credit Rating of ???bbb+??? to the same.
Ensign Group's Unit Sells Urgent Care Assets to MultiCare
by Zacks Equity Research
The Ensign Group, Inc. (ENSG) recently announced that its urgent care unit, Immediate Clinic Seattle, Inc., has completed its asset sale deal with not-for-profit health care organization,
Molina: ACA Repeal Plans a Threat, Buyout Deals on Track
by Zacks Equity Research
On Dec 15, 2016, we issued an updated research report on Molina Healthcare Inc. (MOH).
Community Health to Divest Yakima & Toppenish Hospitals
by Zacks Equity Research
Community Health Systems, Inc. (CYH) recently announced that its subsidiaries have entered into a definitive agreement with Sunnyside Community Hospital & Clinics
Aetna CEO Calls Pulling out of ACA Exchanges 'Good Business'
by Zacks Equity Research
Aetna Inc. (AET) recently came under fire for having allegedly pulled out of Affordable Care Act (ACA) exchanges in 11 states, including the areas covered by the Justice Department lawsuit, in a bid to avoid antitrust claims.
Humana (HUM) to Write off Receivables; Updates Guidance
by Zacks Equity Research
Humana Inc. (HUM) recently announced its decision to write off its receivables of $591 million associated with the risk corridor premium stabilization program outstanding as of Sep 30, 2016.
Humana, FullWell to Enhance Value-Based Care in Colorado
by Zacks Equity Research
Humana Inc. (HUM) recently announced that it has entered in to a value-based agreement with population health leader, FullWell
Will Trump Era Mean Disaster for Health Insurers?
by Mark Vickery
Health insurance companies provided a major overhaul of their business plans to comply with Obamacare, and now they look to be put on a new road forward.
WellCare Health Plans (WCG) and Unit Receive Rating Action
by Zacks Equity Research
WellCare Health Plans, Inc. (WCG) recently received rating action from credit rating giant, Moody's Investors Service, a wing of Moody's Corp. (MCO).
UnitedHealth & CVS Pharmacy Partner to Improve Healthcare
by Zacks Equity Research
In keeping with the intention to provide convenient and low healthcare option to customers, UnitedHealth Group Inc.'s (UNH) pharmacy care services business - OptumRx - recently joined forces with CVS Pharmacy
Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma
by Zacks Equity Research
Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma
Humana Partners DaVita Unit to Enhance MA Plans in Florida
by Zacks Equity Research
Humana Inc. (HUM) recently joined forces with JSA Medical Group to add one primary care practice to its Florida Medicare Advantage (MA) Plan Networks.
Health Insurers Face Regulatory Scrutiny, Exchange Issues
by Zacks Equity Research
Legislation has undoubtedly altered the regulatory landscape in ways that are not always beneficial to a private health insurer's bottom line.
New Strong Buy Stocks for September 2nd
by Indradip Ghosh
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
New Strong Buy Stocks for July 26th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
Health Insurers Suffer on High Costs, Unprofitable Exchanges
by Zacks Equity Research
A fragile global economy presents a headwind for insurers looking to expand their international operations.
Stock Market News for June 03, 2016
by Zacks Equity Research
Benchmarks finished in the green on Thursday following encouraging U.S. private sector jobs data and gains in healthcare stocks
U.S. Health Insurers Provide Defense Amid Volatility
by Zacks Equity Research
The population of Medicare beneficiaries will grow by 36% by the end of this decade, led by a vast aging baby boomer population.
Health Insurance Stock Outlook - Feb. 2016
by Zacks Equity Research
The ACA law has been in place for almost six years now, and has mostly been absorbed by the industry.
Will Election 2016 Mean New Challenges for Health Insurers?
by Zacks Equity Research
Presidential candidates are looking at ways to fine tune the provisions of the healthcare legislation, which, if implemented, will see insurers reworking their business strategies.